Q3 FY2026 · ended Sep 30, 2026 · Revenue $473.60M, +7.2% YoY · Filed Nov 4, 2026
Innospec Inc. (IOSP) files with the SEC under industry code 2800, Chemicals & Allied Products. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $473.6 million and net income of $31.8 million. As of Sep 30, 2026 it held $251.9 million in cash and investments and $47.3 million in total debt.
Revenue
$473.60M
+7.2% vs year-ago quarter
Net income
$31.80M
+3.2% vs prior quarter
Operating cash flow
$17.40M
-55.5% vs year-ago quarter
Free cash flow
—
EPS
$1.29
+148.1% vs year-ago quarter
Dividend per share
$0.00
-100.0% vs year-ago quarter
Shares outstanding
24.63M
-0.6% vs year-ago quarter
Net cash
$204.60M
Q3 FY2026
Operating margin
8.8%
TTM
Company profile
- Industry
- Chemicals & Allied Products (SIC 2800)
- Listed as
- IOSP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Englewood, CO
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1054905
- Former names
- OCTEL CORP (until Jan 9, 2006)
Other Chemicals & Allied Products companies
- Akzo Nobel NV AKZOY
- Solstice Advanced Materials Inc. SOLS
- Balchem Corp BCPC
- Perimeter Solutions, Inc. PRM
- Ingevity Corp NGVT
- Chemours Co CC
- OLIN Corp OLN
- Huntsman CORP HUN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $473.6M | $491.4M | $453.2M | $455.6M | $441.9M |
| Operating income | $41.7M | $39.7M | $36.5M | $46.8M | $5.9M |
| Net income | $31.8M | $30.8M | $30.4M | — | — |
| Diluted EPS | $1.29 | $1.25 | $1.22 | — | $0.52 |
| Operating cash flow | $17.4M | $7.2M | $17.6M | $60.4M | $39.1M |
| Total assets | $1.9B | $1.8B | $1.8B | $1.8B | $1.8B |
| Total liabilities | $476.3M | $495.2M | $467.6M | $499.5M | $496.5M |
| Stockholders' equity | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B |
| Cash and investments | $251.9M | $250.2M | $289.1M | $292.5M | $270.8M |
| Total debt | $47.3M | $47.9M | $50.6M | $52.7M | $49.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 4, 2026 | Jun 2, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2026 | May 8, 2026 |
All 1009 Innospec Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.